XPH News and Press, SPDR S&P Pharmaceuticals From 03/18/24

2024-03-18 12:23:05 ET More on SPDR S&P Pharmaceuticals ETF Seeking Alpha’s Quant Rating on SPDR S&P Pharmaceuticals ETF Dividend scorecard for SPDR S&P Pharmaceuticals ETF Read the full article on Seeking Alpha For further details see: ...

2024-03-13 10:10:00 ET Summary Jeff Hirsch, editor-in-chief of The Stock Trader’s Almanac, and Carter Worth, CEO and founder of Worth Charting, discuss their outlook for 2024 with MoneyShow's Mike Larson. Jeff expects a strong year for stocks, with gains of 8-15% broadly sp...

2024-03-09 03:59:00 ET Summary Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery. Biot...

2024-02-23 04:05:00 ET Summary Within healthcare, an area that has been negatively impacted the last couple of years is the pharmaceutical manufacturing value chain. Several capital goods and materials sectors experienced recessionary conditions last year, which caused weak fundam...

2024-02-18 00:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-07 01:53:00 ET Summary A sub-$3trn 2023 for M&A, but new year pipeline gives hope. Rising follow-on equity in 2023 signals latent appetite. Unstoppable debt capital markets hit $8.9trn for FY2023. By Lucille Jones, Senior Manager, Deals Intelligence and...

2024-02-04 08:05:00 ET Summary Bristol-Myers Squibb has faced revenue stagnation and a decline in stock price, but recent Q4 results suggest a potential rebound in top-line growth. BMY's in-line and new product portfolio showed strong sales growth, driven by top drugs like Eliquis...

Amphenol Corporation (NYSE: APH) announced today that its Board of Directors approved the first quarter 2024 dividend on its Common Stock in the amount of $0.22 per share at its meeting held on January 31, 2024. The Company will pay this first quarter 2024 dividend on April 10, 2024 to shareholde...

2024-01-31 04:36:00 ET Summary 2023 was characterized by narrow leadership and multiple expansions. While last year’s gains have led to headline valuations appearing stretched, there are many segments of the market that are not as aggressively priced. With the expectati...

Transaction highlights: To acquire Carlisle Interconnect Technologies for $2.0 billion in cash Adds leading capabilities in harsh environment interconnect solutions Broad product portfolio highly complementary to Amphenol’s existing interconnect solutions Accelerates lo...